231 related articles for article (PubMed ID: 19557879)
1. Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice.
Shi B; Wang Z; Jin H; Chen YW; Wang Q; Qian Y
Int Immunopharmacol; 2009 May; 9(5):582-6. PubMed ID: 19557879
[TBL] [Abstract][Full Text] [Related]
2. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
3. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
[TBL] [Abstract][Full Text] [Related]
5. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
Kaminitz A; Mizrahi K; Askenasy N
Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
[TBL] [Abstract][Full Text] [Related]
6. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
7. Treatment with Cordyceps sinensis enriches Treg population in peripheral lymph nodes and delays type I diabetes development in NOD mice.
Wang MF; Zhu QH; He YG
Pharmazie; 2013 Sep; 68(9):768-71. PubMed ID: 24147346
[TBL] [Abstract][Full Text] [Related]
8. The Th17/Treg imbalance in patients with acute coronary syndrome.
Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH
Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918
[TBL] [Abstract][Full Text] [Related]
9. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
10. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC
J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352
[TBL] [Abstract][Full Text] [Related]
11. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
12. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
Mor A; Kloog Y; Keren G; George J
Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709
[TBL] [Abstract][Full Text] [Related]
13. Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice.
Bellemore SM; Nikoopour E; Schwartz JA; Krougly O; Lee-Chan E; Singh B
Clin Exp Immunol; 2015 Dec; 182(3):261-9. PubMed ID: 26250153
[TBL] [Abstract][Full Text] [Related]
14. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function.
Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A
Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372
[TBL] [Abstract][Full Text] [Related]
15. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice.
Alam C; Bittoun E; Bhagwat D; Valkonen S; Saari A; Jaakkola U; Eerola E; Huovinen P; Hänninen A
Diabetologia; 2011 Jun; 54(6):1398-406. PubMed ID: 21380595
[TBL] [Abstract][Full Text] [Related]
16. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
17. The Treg/Th17 imbalance in Toxoplasma gondii-infected pregnant mice.
Zhang H; Hu X; Liu X; Zhang R; Fu Q; Xu X
Am J Reprod Immunol; 2012 Feb; 67(2):112-21. PubMed ID: 21923716
[TBL] [Abstract][Full Text] [Related]
18. Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2.
Chen Y; Haines CJ; Gutcher I; Hochweller K; Blumenschein WM; McClanahan T; Hämmerling G; Li MO; Cua DJ; McGeachy MJ
Immunity; 2011 Mar; 34(3):409-21. PubMed ID: 21435588
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells.
Singh K; Kadesjö E; Lindroos J; Hjort M; Lundberg M; Espes D; Carlsson PO; Sandler S; Thorvaldson L
Sci Rep; 2015 Jul; 5():12633. PubMed ID: 26224624
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Chinese drugs for activating blood and Chinese drugs for nourishing qi and activating blood on the metastasis of Lewis lung carcinoma in different stages].
Liu S; He LL; Zhang LN
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1638-41. PubMed ID: 23469603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
